远端脏生物标志物与糖尿病病进展有关
Christina L Tamargo1, Steven G Coca2, Heather Thiessen Philbrook1
1Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
JCI insight
|June 23, 2025
概括
尿表皮表皮生长因子 (EGF) 和尿模素 (UMOD) 在预测糖尿病病 (DKD) 进展方面表现有前途. 这些远端管状标记物的较高水平和较慢的衰退与较低的DKD进展风险有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物发现发现
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病病 (DKD) 的进展是一个重大问题.
- 尿路生物标志物对预测DKD有希望,但远端管状标志物研究不足.
- 皮表皮生长因子 (EGF) 和尿素 (UMOD) 是具有潜在预后价值的远端管道标记物.
研究的目的:
- 研究尿路EGF和UMOD与DKD进展的关联.
- 评估EGF和UMOD水平随时间变化和DKD进展之间的关系.
- 评估基线和纵向生物标志物水平与估计的膜过率 (eGFR) 变化之间的联系.
主要方法:
- 利用考克斯回归模型来评估生物标志物与DKD进展的关联.
- 采用混合模型来分析纵向生物标记水平和eGFR变化.
- 在VA NEPHRON-D试验中,包括1,116名患有2型糖尿病,高白蛋白尿和降低EGFR的参与者.
主要成果:
- 较高的EGF和UMOD基线水平独立地与较低的DKD进展风险相关.
- 序列EGF和UMOD测量的较慢下降与DKD进展的风险降低相关.
- 13%的参与者经历了DKD在2.2年的中位数随访期间的进展.
结论:
- 尿液EGF和UMOD可以作为糖尿病病的宝贵预后生物标志物.
- 这些发现突显了远端管状标记物在DKD风险分层中的潜力.
- 进一步的研究可以验证EGF和UMOD在管理DKD的临床使用.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
01:28Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84
01:10Nephrons
3.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.5K
01:24Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
01:24Serum Studies: Renal Function Tests
53
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
53
01:26Nephrotic Syndrome II : Assessment and Medical Management
25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25